Dave Knapp GLP-1 Industry Insider
On The Pen With Dave Knapp
Follow On The Pen With Dave Knapp across the charts and keep up with new listener reviews. Get the updates in your inbox.
Track this podcast · 7 days freeCard required. Cancel anytime. Choose your plan at signup.
Dave Knapp brings you your weekly dose of everything in the news about incretin mimetic, diabetes and obesity therapies, like Zepbound and Mounjaro, Ozempic and Wegovy, and even investigational treatments like CagriSema and Retatrutide!
© 2025 On The Pen With Dave Knapp
Sign up to track rankings and reviews from Spotify, Apple Podcasts and more.